Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mecasermin rinfabate

EU orphan designation number: EU/3/06/399   
Active ingredient: Mecasermin rinfabate
Indication: Prevention of retinopathy of prematurity in neonates of less than 32 weeks of gestational age
Sponsor: Premacure AB
Dag Hammarskjölds väg 60, SE-751 83 Uppsala, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2006 Centralised Orphan - Designation EMEA/OD/031/06 (2006)3922 of 28/08/2006
01/10/2007 Other procedure